109 results
Page 2 of 6
8-K
EX-99.1
b31njfnu1rlx7kszdm94
18 Nov 22
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
4:30pm
8-K
EX-99.1
wwou85752fxd xwpuld
14 Nov 22
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Data Research
8:32am
8-K
EX-99.1
fgdp0lg
31 Aug 22
Mymd Pharmaceuticals Receives Grant from European
8:00am
8-K
EX-99.1
1mb7xjm2k62af4n7
3 Aug 22
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
vweegw
26 Jul 22
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
ro4ttmaxa1ku2owi5c
12 Jul 22
Bascom Palmer Eye Institute ranked the #1 eye hospital in the United States for 20 years in a row by U.S. News & World Report
4:05pm
8-K
EX-99.1
r17 dbkqimk7dgq4
21 Jun 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
r7kcb5agir8ffc3zw
13 Apr 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
v6u17 6rr4tgwjqn
23 Feb 22
Regulation FD Disclosure
12:02pm
8-K
EX-99.1
yq6guod
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am
8-K
EX-99.1
lao r32cz77mrtz
5 Jan 22
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
9:28am
8-K
EX-99.1
8xl47
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am